Author results

5HD4
  • Download 5hd4
  • View 5hd4
Molmil generated image of 5hd4
DISSECTING THERAPEUTIC RESISTANCE TO ERK INHIBITION RAT WILD TYPE SCH772984 IN COMPLEX WITH (3R)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL)PHENYL]PIPERAZIN-1-YL}ETHYL)-N-[3-(PYRIDIN-4-YL)-2H-INDAZOL-5-YL]PYRROLIDINE-3-CARBOXAMIDE
Descriptor:Mitogen-activated protein kinase 1, (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide, SULFATE ION, ...
Authors:Jha, S., Morris, E.J., Hruza, A., Mansueto, M.S., Schroeder, G., Arbanas, J., McMasters, D., Restaino, C.R., Dayananth, R., Black, S., Elsen, N.L., Mannarino, A., Cooper, A., Fawell, S., Zawel, L., Jayaraman, L., Samatar, A.A.
Deposit date:2016-01-04
Release date:2016-02-24
Last modified:2016-06-01
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:Dissecting Therapeutic Resistance to ERK Inhibition.
Mol.Cancer Ther., 15, 2016
5HD7
  • Download 5hd7
  • View 5hd7
Molmil generated image of 5hd7
DISSECTING THERAPEUTIC RESISTANCE TO ERK INHIBITION RAT MUTANT SCH772984 IN COMPLEX WITH (3R)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL)PHENYL]PIPERAZIN-1-YL}ETHYL)-N-[3-(PYRIDIN-4-YL)-2H-INDAZOL-5-YL]PYRROLIDINE-3-CARBOXAMIDE
Descriptor:Mitogen-activated protein kinase 1, (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide, SULFATE ION
Authors:Jha, S., Morris, E.J., Hruza, A., Mansueto, M.S., Schroeder, G., Arbanas, J., McMasters, D., Restaino, C.R., Dayananth, R., Black, S., Elsen, N.L., Mannarino, A., Cooper, A., Fawell, S., Zawel, L., Jayaraman, L., Samatar, A.A.
Deposit date:2016-01-04
Release date:2016-02-24
Last modified:2017-11-22
Method:X-RAY DIFFRACTION (1.69 Å)
Cite:Dissecting Therapeutic Resistance to ERK Inhibition.
Mol.Cancer Ther., 15, 2016